Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19
Luke Milross, Joaquim Majó, Nigel Cooper, et al.
The Lancet Respiratory Medicine (2021) Vol. 10, Iss. 1, pp. 95-106
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long Covid
Danilo Buonsenso, Leonardo Di Gennaro, Cristina De Rose, et al.
Future Microbiology (2022) Vol. 17, Iss. 7, pp. 551-571
Open Access | Times Cited: 81
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
Katja Hönzke, Benedikt Obermayer, Christin Mache, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2102725-2102725
Open Access | Times Cited: 43
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
COVID-19-Related ARDS: Key Mechanistic Features and Treatments
John Selickman, Charikleia S. Vrettou, Spyros D. Mentzelopoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4896-4896
Open Access | Times Cited: 31
Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury
Yiheng Mao, Ying Chen, Yuan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113689-113689
Open Access | Times Cited: 8
Modulation of alveolar macrophage and mitochondrial fitness by medicinal plant-derived nanovesicles to mitigate acute lung injury and viral pneumonia
Lusha Ye, Yanan Gao, Simon Wing Fai Mok, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells
Sami Giryes, Nicola Luigi Bragazzi, Charlie Bridgewood, et al.
Seminars in Immunopathology (2022) Vol. 44, Iss. 3, pp. 375-390
Open Access | Times Cited: 22
Diffuse alveolar damage patterns reflect the immunological and molecular heterogeneity in fatal COVID-19
Jonas S. Erjefält, Natália de Souza Xavier Costa, Jimmie Jönsson, et al.
EBioMedicine (2022) Vol. 83, pp. 104229-104229
Open Access | Times Cited: 22
Lung T cell response in COVID-19
Mehrnoush Hadaddzadeh Shakiba, Ioanna D. Gemünd, Marc Beyer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response
Sandra L. Leibel, Rachael N. McVicar, Rabi Murad, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 30
Open Access | Times Cited: 4
Association between Coagulation Profile and Clinical Outcome in Children with SARS-CoV-2 Infection or MIS-C: A Multicenter Cross-Sectional Study
Danilo Buonsenso, Francesco Mariani, Luca Pierri, et al.
Children (2022) Vol. 9, Iss. 2, pp. 279-279
Open Access | Times Cited: 18
The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections
Simon De Neck, Rebekah Penrice-Randal, Jordan J. Clark, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1637-1637
Open Access | Times Cited: 10
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19
Jimmy Tsz Hang Lee, Sam N. Barnett, Kenny Roberts, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A robust platform for integrative spatial multi‐omics analysis to map immune responses to SARS‐CoV‐2 infection in lung tissues
Xiao Tan, Laura F. Grice, Minh Tran, et al.
Immunology (2023) Vol. 170, Iss. 3, pp. 401-418
Open Access | Times Cited: 9
Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
Kim R Chiok, Neeraj Dhar, Arinjay Banerjee
iScience (2023) Vol. 26, Iss. 5, pp. 106629-106629
Open Access | Times Cited: 8
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020–2022: A Scoping Review
Émeline Maisonneuve, Odette de Bruin, Guillaume Favre, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4519-4519
Open Access | Times Cited: 6
Akute Nierenschädigung und COVID-19: pulmorenaler Crosstalk unter massiver Inflammation
Timo Mayerhöfer, Fabian Perschinka, Michael Joannidis
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2022) Vol. 117, Iss. 5, pp. 342-348
Open Access | Times Cited: 9
Moderate to severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality
Adel Maamar, Pauline Guillot, Vincent Joussellin, et al.
ERJ Open Research (2023) Vol. 9, Iss. 2, pp. 00554-2022
Open Access | Times Cited: 4
Viral uptake and pathophysiology of the lung endothelial cells in age‐associated severe SARS‐CoV‐2 infection models
Takuya Tsumita, Ryo Takeda, Nako Maishi, et al.
Aging Cell (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 4
Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19
Luke Milross, Bethany Hunter, David McDonald, et al.
EBioMedicine (2023) Vol. 99, pp. 104945-104945
Open Access | Times Cited: 4
Silent Hypoxemia in the Emergency Department: A Retrospective Cohort of Two Clinical Phenotypes in Critical COVID-19
Karine Alamé, Elena Laura Lemaitre, Laure Abensur Vuillaume, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5034-5034
Open Access | Times Cited: 7
Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels
О. Ya. Porembskaya, В. Н. Кравчук, Maxim I. Galchenko, et al.
Rational Pharmacotherapy in Cardiology (2022) Vol. 18, Iss. 4, pp. 376-384
Open Access | Times Cited: 7
Obesity and diabetes mellitus are associated with SARS-CoV-2 outcomes without influencing signature genes of extrapulmonary immune compartments at the RNA level
Jöran Lücke, Marius Böttcher, M. Nawrocki, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24508-e24508
Open Access | Times Cited: 1
Cytokine storm in COVID-19 and other diseases: emerging therapeutic interventions
Shivani Sahu, Renu Dharra, Manisha Gun, et al.
Elsevier eBooks (2024), pp. 209-241
Closed Access | Times Cited: 1
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit
Francesco Ferro, Gaetano La Rocca, Elena Elefante, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7273-7273
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top